ertugliflozin 2.5 MG / metformin hydrochloride 1000 MG Oral Tablet
- RxCUI
- 1992685
- RxNorm name
- ertugliflozin 2.5 MG / metformin hydrochloride 1000 MG Oral Tablet
- Display name
- ertugliflozin 2.5 MG / metformin hydrochloride 1000 MG Oral Tablet
- Full name
- ertugliflozin 2.5 MG / metformin hydrochloride 1000 MG Oral Tablet
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:13
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SEGLUROMET | ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Merck Sharp & Dohme LLC | a6aeb99a-ce49-4125-90ce-642df3f1ebad | 2026-08-11 | Boxed warning, Warnings, Adverse reactions | 1992685 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a6aeb99a-ce49-4125-90ce-642df3f1ebad | ertugliflozin 2.5 MG / metFORMIN hydrochloride 1000 MG Oral Tablet [PSN] · ertugliflozin 2.5 MG / metformin hydrochloride 1000 MG Oral Tablet [SCD] | 2 | 19 | These highlights do not include all the information needed to use SEGLUROMET safely and effectively. See full prescribing information for SEGLUROMET. SEGLUROMET ® (ertugliflozin and metformin hydrochloride) tablets, for oral use Initial U.S. Approval: 2017 | 20241220 |
| 9f720024-c68c-420c-aad7-c575237b6d39 | ertugliflozin 2.5 MG / metFORMIN hydrochloride 1000 MG Oral Tablet [PSN] · ertugliflozin 2.5 MG / metformin hydrochloride 1000 MG Oral Tablet [SCD] | 2 | 1 | These highlights do not include all the information needed to use SEGLUROMET safely and effectively. See full prescribing information for SEGLUROMET. SEGLUROMET ® (ertugliflozin and metformin hydrochloride) tablets, for oral use Initial U.S. Approval: 2017 | 20221113 |